MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. (Q39749134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

colorectal adenocarcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gregor Tevž

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

S Vidic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G Sersa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Coer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

U Kamensek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Kranjc

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Cemazar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

1 reference

22 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

409-419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20094071%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2009.87

17 January 2020

exact match

0 references

cites work

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

K-ras mutations in non-small-cell lung carcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Mutations of the BRAF gene in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Use of orlistat (xenical) to treat chylous ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

In vivo electroporation for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

RNAi in human cells: basic structural and functional features of small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

The silent treatment: siRNAs as small molecule drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

K-ras mutations in patients with early colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Electric pulse-mediated gene delivery to various animal tissues

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021

Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.87

7 January 2021